
Tiwa Adebayo
Bloomberg reporter covering European markets and equities, providing market color and company-specific reporting on stocks affected by energy prices and geopolitical events.
Top 5 podcasts with Tiwa Adebayo
Ranked by the Snipd community

Apr 2, 2026 • 4min
BP Up, Lufthansa Down, Fresnillo Drops
Tiwa Adebayo, Bloomberg reporter on European markets and equities. She explains how a surge in oil after President Trump’s Iran comments sent stocks and bonds lower. She covers BP’s gains from higher crude. She discusses airlines, including Lufthansa, facing fuel-cost risks and why miners like Fresnillo fell amid tariff and energy uncertainty.

Apr 1, 2026 • 5min
Rolls-Royce Gains, Lufthansa Rises, Berkeley Tumbles
Tiwa Adebayo, Bloomberg reporter covering markets and companies, breaks down big movers. Rolls‑Royce jumps on defense and energy interest. Airlines navigate Middle East risks and contingency planning. UK housebuilder Berkeley tumbles after sharply cut profit outlook tied to regional uncertainty.

Mar 30, 2026 • 5min
Rio Tinto Jumps, Sodexo Gains, BFF Bank Slumps
Tiwa Adebayo, Bloomberg markets reporter known for clear European stock analysis. She explains Rio Tinto’s rally linked to Middle East strikes and shipping resumption. She covers Sodexo’s boost after a Jefferies upgrade and leadership change. She outlines BFF Bank’s dramatic plunge after a loan-classification review and regulatory scrutiny.

Mar 30, 2026 • 4min
Rio Tinto Jumps, Sodexo Gains, Boohoo Rises
Tiwa Adebayo, Bloomberg reporter covering European markets and corporate news. She breaks down how Iran's strikes pushed aluminium prices and lifted mining stocks. She covers Sodexo's upgrade, upcoming results and leadership change. She highlights Boohoo beating FY26 guidance and signs of a successful turnaround.

Mar 27, 2026 • 4min
Enagas Soars, AstraZeneca Gains, Pernod Ricard Rises
Tiwa Adebayo, Bloomberg equities reporter who covers European markets on the ground. She breaks down Enagas's surge after a regulator's draft proposal. She covers AstraZeneca’s COPD trial news and its market implications. She discusses Pernod Ricard’s reported talks about Brown‑Forman and potential U.S. market impact.


